FundedIQ
Health Care

Syntropic

Syntropic is a company that specializes in medical devices and creating innovative technologies to aid in treating psychiatric illnesses and enhancing cognitive functions.

www.syntropicmedical.com Austria, Philippines 1-10 employees
Total raised
$1.2M
Rounds
3
Latest
Series Unknown
Dec 2025

Syntropic is a company that specializes in medical devices and creating innovative technologies to aid in treating psychiatric illnesses and enhancing cognitive functions.

Syntropic has raised $1.2M across 3 rounds. Its most recent round was a Series Unknown in Dec 2025. Full funding history, investors, and team are detailed below.

Funding history

3 rounds · 1 visible Unlock with plan

3 rounds on record — latest round shown, the rest unlock with a paid plan.

Date
Round
Amount
Lead investor
Dec 4, 2025
Series Unknown
Undisclosed

Unlock 2 earlier rounds — dates, amounts, round types — plus the lead investor for every round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Syntropic is featured in

Similar companies

Lavanda Holistic Clinic

Convenient medicine right at your door. Access integrative practices including telehealth, acupuncture, cupping, and supplements through licensed naturopathic doctors that dedicate an hourly visit at your location within an inviting, fully equipped van.

Seed $750k
Heartbeat of Football Foundation

The Heartbeat of Football is a non-profit organization. It aims to promote healthy hearts in sports by educating players, reducing health hazards, and installing defibrillators on all playing fields nationwide.

Series Unknown $150k
Mediclick

A digital platform called Mediclick PH links Filipinos to healthcare treatments and products. We began operations in 2020 and have since emerged as the Philippines' platform with the quickest rate of growth for healthcare delivery. Since that time, we've been on a mission to transform our company from a marketplace to an open, integrated platform that covers the full healthcare continuum and offers truly holistic healthcare.

Seed $300k
Ognomy Sleep

Ognomy is transforming the $10B+ sleep health market by delivering fast, convenient, insured virtual care for obstructive sleep apnea (OSA). With a 50-state sleep medicine clinician network and in-network coverage for 200M+ lives, Ognomy makes high-quality sleep apnea care accessible at national scale. Our proprietary cloud platform, enhanced by AI-driven workflow tools, streamlines operations and empowers clinicians — enabling faster diagnosis and better patient outcomes while maintaining a patient-first approach. With 25,000+ patients cared for and an 81 NPS, our results speak for themselves.

Series A $20.0M
LTC

LTC Properties, Inc. is a self-administered real estate investment trust that invests primarily in the long-term care sector of the health care industry through the origination of first mortgage loans and acquisition of properties that are leased to numerous long-term care providers. LTC Properties operates in accordance with federal tax laws and regulation governing real estate investment trusts, which enables the Company's income to be distributed to its stockholders without federal tax liability to the Company.

Series Unknown $300M
CraniUS

CraniUS is a manufacturer of medical equipment.

Series Unknown $1.1M
Adherium

Adherium (previously known as Nexus6) is a privately owned developer and manufacturer of solutions that help patients and their healthcare professionals monitor and increase patient adherence to prescribed therapies, leading to improved disease management and reduced healthcare costs.

Series Unknown $1.7M
Beams

Beams is a producer of medical devices for cancerology based on the use of particles β.

Series Unknown $1.7M
Neurobell

NeuroBell are developing a novel medical device providing portable EEG monitoring with real-time &automated neonatal seizure alerts at the bedside.

Series Unknown $5.5M
Mykare Health

Mykare Health is constructing the largest affordable and reliable hospital network in India. So far, Mykare has served over 70,000 patients in more than 12 cities across India. Their network consists of over 60 hospitals with a capaUK over 2000 beds and they have treated over 5000 international patients. Additionally, they have a team of over 60 members. Established in 2021, Mykare Health is the fastest-growing platform in India for elective surgeries. They specialize in minimally invasive procedures such as lasik, hernia repair, piles treatment, hair transplant, liposuction, knee replacement, hip replacement, and IVF. The company offers several benefits to its customers, including 24/7 quality care, transparent pricing, financing options at no extra cost, and administrative support. These services address the issues of information accessibility and financing that exist in the industry. Operating on an asset-light model, Mykare provides elective surgeries at discounted rates ranging from 20-30% by utilizing the underused infrastructure of hospitals and surgeons. Mykare is proud to be the first US-accelerated company from Kerala and has been recognized as the best startup to watch by Inc42. They have also received the prestigious Best Startup of the Year 2022 award from Tie and Sambharabham Business Magazine.

Series A $1.0M
Topanga Ridge

Topanga Ridge Group is an integrated mental-health practice that provides discreet, referral-driven therapy by combining ancestral/ritual healing with current professional approaches and virtual services.

Series Unknown $20k
SuperLiving

SuperLiving is a lifestyle-tech platform designed for Bharat that aims to make everyday life more attentive and supportive.

Series A $7.0M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.